Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.09
Delayed Data
As of Jun 27
 -0.27 / -6.19%
Today’s Change
2.96
Today|||52-Week Range
28.08
-73.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues2.2M1.0M1.8M1.3M
 
 
 
 
 
Depreciation And Amortization966.0K1.0M1.1M995.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses34.0M32.4M34.1M36.0M
 
 
 
 
 
Research And Development26.5M24.7M23.9M27.4M
 
 
 
 
 
Total Operating Expenses34.9M33.4M35.2M37.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-32.8M-32.4M-33.4M-35.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.4M-32.0M-32.7M-34.7M
 
 
 
 
 
Net Income-32.4M-32.0M-32.7M-34.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS98.5M98.6M98.7M98.7M
 
 
 
 
 
Shares To Calculate EPS Diluted98.5M98.6M98.7M98.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.32-$0.33-$0.35
 
 
 
 
 
EPS Diluted-$0.33-$0.32-$0.33-$0.35